A Prospective Study of Cytomegalovirus, Herpes Simplex Virus 1, and Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Conflicting evidence exists implicating infectious disease in the pathological processes leading to coronary heart disease (CHD). The objective of this article is to describe the relationship of previous infection with cytomegalovirus (CMV) and herpes simplex virus 1 to incident CHD in a population-based cohort study. METHODS: Using a nested case-cohort design from the Atherosclerosis Risk in Communities Study, antibody levels to CMV and herpes simplex virus 1 were determined in serum samples that had been frozen at the baseline examination in participants free of CHD. Determinations were made in those who developed incident CHD (n=221) during follow-up of up to 5 years from baseline and in a stratified random sample of all participants (n=515). RESULTS: The population with the highest antibody levels of CMV (approximately the upper 20%) showed an increased relative risk (RR) of CHD of 1.76 (95% confidence interval, 1.00-3.11), adjusting for age, sex, and race. After adjustment for additional covariates of hypertension, diabetes, years of education, cigarette smoking, low-density lipoprotein and high-density lipoprotein cholesterol levels, and fibrinogen level, the RR increased slightly. Based on a priori hypotheses, the RR of CHD at the highest antibody levels in individuals with diabetes was particularly large but with wide confidence intervals (RR, 9.2; 95% confidence interval, 1.8-47.0), and the interaction between high levels of antibody to CMV and diabetes was statistically significant (P=.05). There was no association of CHD with the highest herpes simplex virus 1 antibody levels (adjusted RR, 0.77; 95% confidence interval, 0.36-1.62). CONCLUSIONS: High levels of CMV antibodies are significantly associated with incident CHD. Infection with CMV, particularly in more susceptible disease states such as diabetes, may be an important risk factor for CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“Fasting plasma levels of low-density lipoprotein cholesterol (LDL-C) were calculated using the Friedewald formula after determination of total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels.(11) Years of education were determined and classified as less than high school graduate (low), equal…”
Method(1989) · PubMed · Cited by 3,139
Chronic infections and coronary heart disease: is there a link?
Danesh, J., Collins, R., & Peto, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03079-1 · Cited by 1,211 · cited 3×
“Of related importance is the finding that shows increased atherosclerosis in immunosuppressed heart transplant recipients infected with CMV.(1) However, a recent study(16) of another infectious agent hypothesized to be related to CHD (Chlamydia pneumoniae) did not find a significant relationship in patients with diabe…”
BackgroundWhite, A. D., Folsom, A. R., Chambless, L. E., Sharret, A. R., Yang, K., Conwill, D., Higgins, M., Williams, O. D., Tyroler, H. A., & The ARIC Investigators (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00041-0 · Cited by 688 · cited 2×
“A classification committee reviewed and adjudicated all potential clinical CHD events using published criteria based on symptoms, electrocardiographic findings, and cardiac enzyme levels for hospitalized cases.(6) Coronary revascularization was defined as present when hospital procedure codes included coronary bypass,…”
BackgroundMethodSelf-citationLibby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Robust Variance Estimation for the Case-Cohort Design
Barlow, W. E. (1994) · Biometrics · doi:10.2307/2533444 · Cited by 540 · cited 4×
“The statistical modeling of the RR of clinical CHD for the specified characteristics was done using a proportional hazards model that was modified to take the sampling structure into account using the method of Barlow.12 Several previous hypotheses regarding interactive effects were investigated.”
MethodInfluentialMiettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Ronnemaa, T., Pyorala, K., & Laakso, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014934 · Cited by 447
Chiu, B., Viira, E., Tucker, W., & Fong, I. W. (1997) · Circulation · doi:10.1161/01.cir.96.7.2144 · Cited by 307
Nieto, F. J., Adam, E., Sorlie, P., Farzadegan, H., Melnick, J. L., Comstock, G. W., & Szklo, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.922 · Cited by 303 · cited 3×
“Of related importance is the finding that shows increased atherosclerosis in immunosuppressed heart transplant recipients infected with CMV.1 However, a recent study16 of another infectious agent hypothesized to be related to CHD (Chlamydia pneu- moniae) did not find a significant relationship in patients with diabete…”
BackgroundSelf-citationHIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS
Adam, E., Probtsfield, J. L., Burek, J., Mccollum, C. H., Melnick, J. L., Petrie, B. L., Bailey, K. R., & Debakey, M. E. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90888-9 · Cited by 290
Self-citation
Cited by
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
Simanek, A. M., Dowd, J. B., Pawelec, G., Melzer, D., Dutta, A., & Aiello, A. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016103 · Cited by 396
Folsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., Heiss, G., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 358
Self-citationSÖDERBERG‐NAUCLÉR, C. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01618.x · Cited by 349
Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease
Britt, W. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_23 · Cited by 345
Roberts, E. T., Haan, M. N., Dowd, J. B., & Aiello, A. E. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq177 · Cited by 281
“More recently, CMV has been linked with cancer (3), cardiovascular disease (4, 5), cognitive functioning includ-”
BackgroundResultInflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
Esenwa, C. C., & Elkind, M. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.125 · Cited by 281
Wang, G. C., Kao, W. H. L., Murakami, P., Xue, Q.-L., Chiou, R. B., Detrick, B., McDyer, J. F., Semba, R. D., Casolaro, V., Walston, J. D., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq062 · Cited by 265
DOWD, J. B., AIELLO, A. E., & ALLEY, D. E. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000551 · Cited by 210
“Importantly, CMV has been linked to inflammatory processes, cardiovascular disease, cognitive outcomes, and Alzheimer’s disease [11, 16–20].”
BackgroundSlopen, N., Koenen, K. C., & Kubzansky, L. D. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.003 · Cited by 151
Spyridopoulos, I., Martin‐Ruiz, C., Hilkens, C., Yadegarfar, M. E., Isaacs, J., Jagger, C., Kirkwood, T., & von Zglinicki, T. (2016) · Aging Cell · doi:10.1111/acel.12430 · Cited by 133
Lee, Y.-L., Liu, C.-E., Cho, W.-L., Kuo, C.-L., Cheng, W.-L., Huang, C.-S., & Liu, C.-S. (2014) · Biomarkers · doi:10.3109/1354750x.2013.877967 · Cited by 29
Metadata
- Authors
- Sorlie, P. D., Nieto, F. J., Adam, E., Folsom, A. R., Shahar, E., & Massing, M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-07-10
- Volume
- 160
- Issue
- 13
- Pages
- 2027
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1977775534
- Cited by
- 170
- References
- 18
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.